Public Library of Science
Browse
Figure_4.tif (932.3 kB)

Kaplan Meyer plots of progression free survival (PFS) (A) and overall survival (OS) (B) in 35 metastatic melanoma patients treated with bevacizumab monotherapy.

Download (0 kB)
figure
posted on 2012-06-15, 00:53 authored by Cornelia Schuster, Hans P. Eikesdal, Hanne Puntervoll, Jürgen Geisler, Stephanie Geisler, Daniel Heinrich, Anders Molven, Per E. Lønning, Lars A. Akslen, Oddbjørn Straume

Early hypertension (EH) was significantly associated with PFS (C) and OS (D).

History

Usage metrics

    PLOS ONE

    Categories

    Keywords

    meyerplotsprogression35metastaticmelanomapatientstreatedbevacizumab

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC